There are studies showing insults to the BBB in neuropsychiatric SLE (see #msg-56694303), but this is not likely in the case because patients with active central nervous system (CNS) lupus were excluded in the phase III benlysta trials.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.